Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Deletion”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableLooking for participantsNCT05653544
What this trial is testing

Natural History in Primary Mitochondrial Myopathies

Who this might be right for
Primary Mitochondrial Myopathies
Cristina Domínguez González 150
Not applicableNot Yet RecruitingNCT06662591
What this trial is testing

Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study

Who this might be right for
Autism Spectrum Disorder (ASD)
Research and Treatment Society of Genetic Disorders 3,000
Not applicableStudy completedNCT01156168
What this trial is testing

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

Who this might be right for
Breast Cancer
ECOG-ACRIN Cancer Research Group 363
Not applicableStudy completedNCT05306067
What this trial is testing

Plasmodium Falciparum Genomic Intelligence in Mozambique

Who this might be right for
Malaria,FalciparumMalaria in PregnancyMalaria
Centro de Investigacao em Saude de Manhica 21,848
Not applicableLooking for participantsNCT07014020
What this trial is testing

RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS)

Who this might be right for
Phelan-McDermid SyndromeSHANK3 Haploinsufficiency
Peking University First Hospital 8
Not applicableStudy completedNCT01365949
What this trial is testing

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 40
Not applicableUnknownNCT05111080
What this trial is testing

Partial PTEN Deletion in Breast Cancer

Who this might be right for
PTEN Gene Deletion
Assiut University 40
Early research (Phase 1)Looking for participantsNCT07361562
What this trial is testing

A Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more
Cogent Biosciences, Inc. 100
Not applicableWithdrawnNCT01350180
What this trial is testing

Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

Who this might be right for
Prostate Cancer
Dr. Tamim Niazi
Not applicableUnknownNCT02317965
What this trial is testing

Non-Invasive Screening for Fetal Aneuploidy

Who this might be right for
Down SyndromeEdwards Syndrome
Progenity, Inc. 340
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Early research (Phase 1)Looking for participantsNCT06308419
What this trial is testing

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Who this might be right for
LeiomyosarcomaSoft-tissue Sarcomas
M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT03319979
What this trial is testing

DHFR 19 bp Deletion Polymorphism and Folic Acid Utilization

Who this might be right for
Characterize rs70991108 Polymorphism of DHFR Gene
Tufts University 117
Post-approval studies (Phase 4)Study completedNCT02514174
What this trial is testing

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Who this might be right for
Carcinoma, Non-Small-Cell LungErbB Receptors
Boehringer Ingelheim 25
Early research (Phase 1)Active Not RecruitingNCT03993873
What this trial is testing

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorsMET Gene Alterations
Turning Point Therapeutics, Inc. 95
Testing effectiveness (Phase 2)Study completedNCT01243346
What this trial is testing

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

Who this might be right for
D842-related Mutant GIST
Arog Pharmaceuticals, Inc. 20
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Not applicableLooking for participantsNCT06274164
What this trial is testing

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

Who this might be right for
RAI1 Gene 17P11.2 Deletion+Duplication
Baylor College of Medicine 90
Testing effectiveness (Phase 2)UnknownNCT00457314
What this trial is testing

The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease

Who this might be right for
Mitochondrial Myopathy
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 50
Not applicableUnknownNCT00161109
What this trial is testing

Genetics and Psychopathology in the 22q11 Deletion Syndrome

Who this might be right for
Chromosome 22q11.2 Deletion Syndrome
UMC Utrecht 175
Load More Results